Clinical trial
Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)
NCT00207142 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00207142 |
|---|---|
| Title | Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study) |
| Official title | A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing the Efficacy of a Treatment Maintenance Phase With Unboosted vs. Boosted Reyataz After an Induction Phase With Reyataz and Ritonavir in Treatment Naive HIV Patients (the INDUMA Study) |
| Acronym | INDUMA |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Atazanavir + 2 NRTIs, Atazanavir + Ritonavir + 2 NRTIs |
| Enrollment | 252 |
| Start date | Nov 1, 2005 |
| Primary completion | Aug 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | Jan 12, 2010 |
| Countries | Estonia, France, Germany, Ireland, Italy, Latvia, Portugal, Russia, Spain, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: